Boston, MA, United States of America

Robert K K Lee

This inventor holds 3 USPTO granted patents. Top assignees: Massachusetts Institute of Technology, Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert K K Lee. Retrieved from https://idiyas.com/inventor/robert-k-k-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 150(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Robert K K Lee

Introduction

Robert K K Lee is a prominent inventor based in Boston, MA, known for his significant contributions to the field of neurological research. He holds a total of 3 patents that focus on the regulation of amyloid precursor protein (APP) expression and methods for treating neurological disorders.

Latest Patents

One of his latest patents involves the regulation of amyloid precursor protein (APP) expression by the administration of an estrogenic compound. This research has revealed that lipophilic hormones interacting with cytosolic or nuclear receptors can regulate APP expression and synthesis. The studies indicate that treatment of brain cells with estrone or 17β-estradiol leads to a reduction in APP holoprotein expression, which may help mitigate the production of neurotoxic APP fragments. This discovery suggests that estrogen therapy could potentially prevent neurodegenerative and cognitive changes associated with Alzheimer's disease and aging.

Another significant patent by Lee focuses on the composition and methods for treating neurological disorders and neurodegenerative diseases. His findings show that stimulation of β-adrenergic receptors, which activate cAMP formation, results in increased APP and GFAP synthesis in astrocytes. The exposure of neuronal cells to certain β-adrenergic receptor ligands or agonists, such as norepinephrine and isoproterenol, leads to increased APP mRNA transcription and overproduction. This increase can be inhibited by β-adrenergic receptor antagonists, highlighting the potential for regulating APP overexpression and mediating reactive astrogliosis through cAMP signaling.

Career Highlights

Robert K K Lee has worked at the Massachusetts Institute of Technology, where he has contributed to groundbreaking research in the field of neuroscience. His work has implications for the treatment and prevention of various neurological disorders, including Alzheimer's disease.

Collaborations

Lee has collaborated with Richard J Wurtman, further enhancing the impact of his research in the scientific community.

Conclusion

Robert K K Lee's innovative work in the regulation of APP expression and treatment of neurological disorders showcases his dedication to advancing medical science. His patents hold promise for future therapies aimed at combating neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…